期刊文献+

不同治疗方案对婴幼儿哮喘重度发作疗效的对比研究 被引量:2

A comparison of different protocols in treatment of infant asthma at severe attack
原文传递
导出
摘要 将81例哮喘重度发作婴幼儿按就诊顺序分为3组,分别采用布地奈德混悬液+硫酸沙丁胺醇雾化(布地奈德组,28例)、硫酸沙丁胺醇雾化+静脉用甲泼尼龙(甲泼尼龙组,34例)、硫酸沙丁胺醇雾化(硫酸沙丁胺醇组,19例)治疗,对其临床症状、血气变化进行比较。结果组内不同治疗时间患儿呼吸频率、心率、哮鸣音及自我感觉评分均随时问延长而逐渐降低,与治疗前比较差异有统计学意义(q=2.96~163.37,P〈0.05或0.01);组间治疗后4h时,硫酸沙丁胺醇组呼吸频率、心率明显高于布地奈德组(q=3.08、4.10,P〈0.05)和甲泼尼龙组(q=3.24、3.34,P〈0.05),治疗后4、12h时哮鸣音、自我感觉评分硫酸沙丁胺醇组明显高于布地奈德组(q=5.63~23.63,19〈0.01)和甲泼尼龙组(q=6.76~23.72,P〈0.01)。提示婴幼儿哮喘重度发作时,采用布地奈德混悬液吸入治疗可达到与静脉用甲泼尼龙基本相同的效果;单纯支气管扩张剂不能有效控制大多数婴幼儿重度哮喘的发作。 Eighty one infants with severe asthma attacks were randomly divided into three groups: budesonide group (budesonide suspension + ventolin inhalation), methylprednisolone group (Ventolin inhalation + intravenous methylprednisolone ) and ventolin group ( ventolin inhalation alone). Compared with the pre-treatment, the respiratory rate, heart rate, wheeze score, self-feeling score of three groups were gradually reduced (q = 2. 96 - 163.37, P 〈 0. 05 or 0. 01 ). The respiratory rate, heart rate of ventolin group was significantly higher than those of budesonide group (q = 3.08,4. 10, P 〈 0. 05) and methylprednisolone group ( q =- 3.24,3.34 ,P 〈0. 05 ) 4 h after treatment, wheeze score, self-feeling score of ventolin group was significantly higher than budesonide group ( q = 5.63 - 23.63, P 〈 0. 01 ) and methylprednisolone group (q = 6. 76-23.72,P 〈0. 01 ) 4 and 12 h after treatment. Results indicate that budesonide suspension can achieve the same effect as intravenous methylprednisolone and bronchodilators alone may not effectively control the severe asthma attack in infants.
出处 《中华全科医师杂志》 2010年第2期117-119,共3页 Chinese Journal of General Practitioners
关键词 哮喘 治疗结果 Asthma Treatment outcome
  • 相关文献

参考文献8

二级参考文献37

  • 1刘建梅.肺功能检查在小儿哮喘中的应用[J].实用儿科临床杂志,2004,19(10):823-824. 被引量:12
  • 2Lukacs NW, Tekkanat KK. Role of chemokines in asthmatic airway inflammation. Immunol Rev, 2000, 177(10) : 21 - 30.
  • 3Borish L, Rosenwasser L. Th1/Th2 lymphocytes: Doubt some more. J Allergy Clin Immunol, 1997, 99(2) : 161-164.
  • 4Behman RE, Kliegman RN, Jenson HB. NELSON Textbook of Pediatric 16th ed, Harcourt Asia Saunders Co,2001 : 1235- 1251.
  • 5陈育智 见:胡亚美 江载芳 主编.支气管哮喘[A].见:胡亚美,江载芳,主编.诸福棠实用儿科学.第7版[C].北京:人民卫生出版社,2002.638.
  • 6Baker JW, Mellon M, Wald J, et al. A multiple - dosing placebocontrolled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants[J ]. Pediatrics, 1999,1:414 - 421.
  • 7National Institutes of Health National Heart, Lung, and Blood Institute. Global initiative for asthma management and pervention[ M ].NIH Publication No 02 - 3659,2002:130.
  • 8Johnson M. Pharmacodynamics and phamacokinetics if inhaled glucocorticoids[J ]. J Allergy Clin Immunol , 1996,97:1697 - 1763.
  • 9Hung CC, Chen YC, Mao HC, et al. Effects of systematic nursing instruction of mothers on using medication and health status of asthmatic children[J ]. J Nurs Res, 2002,10: 22 - 32.
  • 10Moller C, St romberg L, Oldaeus G, et al. Efficacy of once - daily versus twice- daily administration of budesonide by turbohaler in children with stable asthma[ J ]. Pediatr Pulmonol, 1999,28: 337 -343.

共引文献2705

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部